Sycamore Biopharma, Inc. — Form D
Sycamore Biopharma, Inc. of West Columbia, SC, a company, filed a Form D exempt-offering notice with the SEC on 2019-12-20. The offering totals $500K, of which $500K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2019-12-20
- Form: D
- Accession: 0001797706-19-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $500K
- Amount sold: $500K
- Minimum investment: $100K
- Investors: 5
- Date of first sale: 2019-12-12
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-356130
Issuer
- Name: Sycamore Biopharma, Inc.
- CIK: 0001797706
- Entity type: Corporation
- Jurisdiction: SOUTH CAROLINA
- Incorporated: 2018
- Address: 167 Lott Ct., West Columbia, SC, 29169
- Phone: 803-206-1290
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Mark T Hamann | Director | Columbia, SC |
| William T Lamar | Director | Columbia, SC |
| H. Lee T Mashburn, Jr. | Director | Columbia, SC |
| Mark T Hamann | Executive Officer | Columbia, SC |
| William T Lamar | Executive Officer | Columbia, SC |
| H. Lee T Mashburn, Jr. | Executive Officer | Columbia, SC |
| Chris Sadek | Director | West Columbia, SC |
| R. Tyler Stone III | Director | West Columbia, SC |
| R. Tyler Stone III | Executive Officer | West Columbia, SC |
Other filings by this issuer (1)
More